Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanguisorba officinalis, commonly known as greater burnet or great burnet, is a perennial herb in the Rosaceae family traditionally used in Chinese medicine primarily as a hemostatic agent to stop bleeding and treat burns and scalds. The root (Sanguisorbae radix) is the main medicinal part. Extracts from Sanguisorba officinalis have demonstrated multiple pharmacological effects including anti-cancer, antiviral (notably against hepatitis B virus), anti-inflammatory, antibacterial, neuroprotective (including potential benefits for Alzheimer’s disease and stroke), hepatoprotective, antioxidant, and antidiabetic activities. It has also been used for conditions such as ulcerative colitis, diarrhea, dysentery, bladder problems, hemorrhoids and to promote wound healing. Its mechanism of action is attributed mainly to its astringent properties—helping slow or arrest blood flow—and its rich content of bioactive compounds such as triterpenoids and polyphenols that contribute to its diverse biological effects[1][3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sanguisorba officinalis.